Products & Services · Revenues:

Enbrel (Outside the U.S. and Canada) — Revenues:

Pfizer Enbrel (Outside the U.S. and Canada) — Revenues: decreased by 22.9% to $138.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.4%, from $140.00M to $138.00M. Over 4 years (FY 2021 to FY 2025), Enbrel (Outside the U.S. and Canada) — Revenues: shows a downward trend with a -14.7% CAGR.

Analysis

StatementSegment
First reportedQ1 2016
Last reportedQ1 2026May 5, 2026
Rolls up toTotal Revenue
Metric ID: pfe_segment_enbrel_outside_the_u_s_and_canada_revenues

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$286.00M$283.00M$297.00M$280.00M$257.00M$230.00M$236.00M$199.00M$219.00M$208.00M$203.00M$159.00M$179.00M$169.00M$183.00M$140.00M$154.00M$154.00M$179.00M$138.00M
QoQ Change—-1.0%+4.9%-5.7%-8.2%-10.5%+2.6%-15.7%+10.1%-5.0%-2.4%-21.7%+12.6%-5.6%+8.3%-23.5%+10.0%+0.0%+16.2%-22.9%
YoY Change————-10.1%-18.7%-20.5%-28.9%-14.8%-9.6%-14.0%-20.1%-18.3%-18.8%-9.9%-11.9%-14.0%-8.9%-2.2%-1.4%
Range$138.00M – $297.00M
CAGR-14.2%
Avg YoY Growth-13.9%
Median YoY Growth-14.0%

Frequently Asked Questions

What is Pfizer's enbrel (outside the u.s. and canada) — revenues:?
Pfizer (PFE) reported enbrel (outside the u.s. and canada) — revenues: of $138.00M in Q1 2026.
How has Pfizer's enbrel (outside the u.s. and canada) — revenues: changed year-over-year?
Pfizer's enbrel (outside the u.s. and canada) — revenues: decreased by 1.4% year-over-year, from $140.00M to $138.00M.
What is the long-term trend for Pfizer's enbrel (outside the u.s. and canada) — revenues:?
Over 4 years (2021 to 2025), Pfizer's enbrel (outside the u.s. and canada) — revenues: has grown at a -14.7% compound annual growth rate (CAGR), from $1.19B to $627.00M.